Cargando…
Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study
Background Although a toxic regimen, FOLFIRINOX is one of the most efficient chemotherapy regimens in advanced pancreatic adenocarcinoma. There is no standard number of cycles in locally advanced or metastatic stages. Materials and method The present retrospective study reports the experience of a s...
Autores principales: | Nitipir, Cornelia, Vrabie, Radu, Parosanu, Andreea Ioana, Tulin, Raluca, Cretu, Bogdan, Cursaru, Adrian, Slavu, Iulian, Miron, Adrian, Calu, Valentin, Orlov Slavu, Maria Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654089/ https://www.ncbi.nlm.nih.gov/pubmed/34925974 http://dx.doi.org/10.7759/cureus.19361 |
Ejemplares similares
-
Local recurrence management of extremity soft tissue sarcoma
por: Serban, Bogdan, et al.
Publicado: (2023) -
Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature
por: Parosanu, Andreea, et al.
Publicado: (2022) -
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
por: Stanciu, Ioana-Miruna, et al.
Publicado: (2023) -
Management of Lung Cancer Presenting with Solitary Bone Metastasis
por: Nistor, Claudiu-Eduard, et al.
Publicado: (2022) -
Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort study
por: Nitipir, Cornelia, et al.
Publicado: (2022)